May 28, 2026
CTBH Pathways to Digital Therapeutics Scale Up Workshop Series
Inaugural Session: A-CHESS, CHESS Health, and Beyond
Please join us for this exciting virtual workshop!
May 28, 2026
2:00 – 3:30 pm Eastern
via Zoom
Registration is required. Please register here.
We are excited to announce the first workshop in the CTBH Pathways to Digital Therapeutics Scale Up Workshop Series focused on A-CHESS, the first mobile digital therapeutic to support substance use recovery developed at the University of Wisconsin by the late David Gustafson, PhD, a pioneer in digital health technologies. Dr. Andrew Quanbeck will provide an overview of the broad research base conducted on A-CHESS as well as the important role of implementation science in this work. Hans Morefield, CEO of CHESS Health, will discuss the innovative business models employed by CHESS Health to promote access to and engagement with the A-CHESS mobile intervention suite across diverse conditions and care settings. CTBH Dissemination and Implementation Core leaders will moderate discussion with specific attention to the importance of implementation science in the development and scale up of this innovative intervention.
Presenters
Andrew Quanbeck, PhD, is an Associate Professor at the University of Wisconsin’s Department of Family Medicine & Community Health and an honorary associate of the University of Wisconsin’s Department of Industrial & Systems Engineering. Dr. Quanbeck heads the Implementation Science and Engineering Lab at UW-Madison. His research draws upon concepts from systems engineering to develop innovative approaches to implementing evidence-based practices. Dr. Quanbeck has been principal investigator on numerous NIH-funded R01 grants that use innovative systems engineering approaches to promote the implementation of evidence-based interventions for the prevention and treatment of substance use disorders in healthcare and community settings and led several of the original studies of A-CHESS.
Hans Morefield is the CEO of CHESS Health, a leading digital health company focused on substance use disorder and behavioral health, which was founded to commercialize the A-CHESS app. Since 2017, Hans has led CHESS to serve health plans, providers, and public sector agencies, through which CHESS’s technology and peer team have worked to improve the quality of life of more than a hundred thousand individuals with SUD and co-occurring issues. Prior to joining CHESS, he spent 20 years in a variety of senior executive roles with healthcare technology companies. Hans is a graduate and trustee of Kalamazoo College.
Moderators
Sarah Lord, PhD, is an Associate Professor of Psychiatry and Biomedical Data Sciences at Geisel School of Medicine at Dartmouth College. In addition to her role as founding director of the CTBH D&I Core, Dr. Lord co-directs the Dartmouth Center for Implementation Science and is faculty in the Master of Science for Implementation Science Program at Geisel. With a health technology industry background, her research focuses on developing, testing and implementation of technology-based care approaches for substance use and mental health conditions across diverse populations and settings, with particular attention to ways to accelerate research to practice translation through attention to implementation and sustainability beginning in early-stage research.
Aimee Campbell, PhD, is a Professor of Clinical Psychiatric Social Work in the Department of Psychiatry at Columbia University Irving Medical Center and a Research Scientist at the New York State Psychiatric Institute. Her research focuses on the development and testing of interventions for substance use disorders and co-occurring health and mental health disorders with an emphasis on increasing adoption and implementation of best practice treatments. Dr. Campbell has been involved in substance use disorder treatment and implementation research for over 25 years, including trials focused on digital therapeutics, women’s treatment needs, and culturally responsive services in collaboration with Tribal and Indigenous communities.
Dr. Lord and Dr. Campbell lead the CTBH Dissemination and Implementation Core
About the CTBH D&I Core Pathways to Digital Therapeutic Scale Up Workshop Series
In this series we explore the highly variable pathways from science to scaling of digital therapeutics for substance use and related disorders, with emphasis on how implementation science can play a critical role in the unique scaling journeys. Each workshop, comprised of the specific digital research and business teams, will have a similar structure: brief presentations on the evidence base for the intervention and the business case processes for scale up, followed by a panel discussion moderated by D&I Core Leaders about the role of implementation science in intervention research pre-scale, business partnerships, and the value and direction of research conducted after digital therapeutics for substance use disorders reach the market.